The director of myeloma immunotherapy at University of Pennsylvania discussed cilta-cel's efficacy in lenalidomide-refractory multiple myeloma.
Adam D. Cohen, MD
Advertisement
Articles by Adam D. Cohen, MD
The director of Myeloma Immunotherapy at University of Pennsylvania discussed ciltacabtagene autoleucel's safety profile.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Guess the Therapy Answer October 23, 2025
2
CGTLive®’s Weekly Rewind – October 24, 2025
3
Quarter Century Update: What Were the Most Significant Inflection Points or Breakthroughs in the Field?
4
